10.77% 3.23

IRulya Therapeutics Inc. Common Stock (IRLA)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

IRulya Therapeutics Inc. Common Stock Borsa (IRLA) Ultime notizie

Oct 13, 2026

Quince Therapeutics relaunched as IRulya: Raymond James targeted QNCX stock at USD 72 - ad-hoc-news.de

Oct 13, 2026

Oct 12, 2026

IRulya Therapeutics Inc. (IRLA) Company Information - Simply Wall Street

Oct 12, 2026

IRulya Therapeutics (Nasdaq:IRLA)Stock Analysis - Simply Wall Street

Oct 12, 2026

Diluted net income available to common stockholders of IRulya Therapeutics Inc. – NASDAQ:IRLA - TradingView

Oct 12, 2026

Oct 09, 2026

Quince relaunches as IRulya, going all in on lung disease after Hail Mary merger - Fierce Pharma

Oct 09, 2026

Quince Therapeutics rebrands as IRulya, names new CEO - Investing.com

Oct 09, 2026

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - GlobeNewswire

Oct 09, 2026

A $116 million cash balance on June 30, 2026, is expected to fund IRulya's operations through 2028. - Stock Titan

Oct 09, 2026

PHAT

$7.50

1.35%

ZVRA

$10.27

0.39%

SLDB

$5.74

5.03%

NVCT

$18.93

5.17%

CLYM

$10.91

6.03%

WVE

$3.19

3.24%

IRulya Therapeutics Inc. Common Stock (IRLA)

IRulya Therapeutics Inc. Common Stock Borsa (IRLA) Ultime notizie

Quince Therapeutics relaunched as IRulya: Raymond James targeted QNCX stock at USD 72 - ad-hoc-news.de

IRulya Therapeutics Inc. (IRLA) Company Information - Simply Wall Street

IRulya Therapeutics (Nasdaq:IRLA)Stock Analysis - Simply Wall Street

Diluted net income available to common stockholders of IRulya Therapeutics Inc. – NASDAQ:IRLA - TradingView

Quince relaunches as IRulya, going all in on lung disease after Hail Mary merger - Fierce Pharma

Quince Therapeutics rebrands as IRulya, names new CEO - Investing.com

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - GlobeNewswire

A $116 million cash balance on June 30, 2026, is expected to fund IRulya's operations through 2028. - Stock Titan

Simile a IRLA